That creates uncertainty in areas such as: long-term use beyond typical protocol durations rare side effects that require large sample sizes to detect interactions with complex medication regimens outcomes in special populations such as pregnancy, cancer history, or severe autoimmune disease The right response to uncertainty is not fear, and it is not blind confidence
But anyway that's sort of my hypothesis, which is I don't actually know what's causing Alzheimer's disease, I don't know how to treat it, I don't know if it's treatable once it's in a late enough stage, but I firmly believe that if you can be as insulin-sensitive as possible, for you as an individual you reduce your risk
At this point, many of us have heard about GLP-1 agonist (glucagon-like peptide-1) medications and their effectiveness in managing type 2 diabetes and aiding weight loss
The effects of synbiotic supplementation on some cardio-metabolic risk factors in overweight and obese children: a randomized triple-masked controlled trial
Your cart is empty Browse our collection to find what you need
